Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Work
Year: 2021
Type: article
Abstract: Purpose: Capecitabine plus oxaliplatin (CAPOX) is one of the standard first-line treatments for unresectable, advanced, or metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. Camr... more
Source: Clinical Cancer Research
Institutions Peking University, Peking University Cancer Hospital, Nanjing Drum Tower Hospital, First Affiliated Hospital of Zhengzhou University, Zhejiang Cancer Hospital +11 more
Cites: 44
Cited by: 86
Related to: 10
FWCI: 13.01
Citation percentile (by year/subfield): 100
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze